Radio and PodcastLive Radio & PodcastsScience & Medicine
Cyclophosphamide for myasthenia gravis: a comeback?
Patients with refractory or high-risk myasthenia gravis (MG) respond poorly to conventional immunosuppressive therapy, requiring rescue therapies and often experiencing treatment toxicity. The study discussed in this pod...
About This Episode
Cyclophosphamide for myasthenia gravis: a comeback? is an episode from JNNP podcast by BMJ Group. Patients with refractory or high-risk myasthenia gravis (MG) respond poorly to conventional immunosuppressive therapy, requiring rescue therap...
Podcast
This episode belongs to JNNP podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 17, 2025, 37:58 long, audio available.
Related Episodes
Continue listening to more episodes from JNNP podcast.
Vestibular neurology for the generalist
Jun 16, 2025 - 46:18
Management methods for acute ischaemic stroke
Feb 13, 2025 - 26:38
Nutritional peripheral neuropathies, with Dr. Alexander Rossor
Apr 17, 2024 - 39:42
Distinguishing primary from functional tics
Feb 19, 2024 - 40:02
Nitrous Oxide Abuse
Sep 22, 2023 - 27:45
Brain Fog Demystified
Aug 8, 2023 - 30:15